24
Participants
Start Date
May 28, 2024
Primary Completion Date
July 28, 2024
Study Completion Date
August 15, 2024
Placebo
Subjects will be given an informed consent as per the form submitted to Advarra IRB. 8 randomized subjects will be given placebo for 60 days. Placebo will be formulated as a dietary supplement in veggie capsules with microcrystalline cellulose excipient.
Pep19 2 mg
Subjects will be given an informed consent as per the form submitted to Advarra IRB. 8 randomized subjects will be given 2 mg of Pep19 for 60 days. Placebo will be formulated as a dietary supplement in veggie capsules with microcrystalline cellulose excipient.
Pep19 5 mg
Subjects will be given an informed consent as per the form submitted to Advarra IRB. 8 randomized subjects will be given 5 mg of Pep19 for 60 days. Placebo will be formulated as a dietary supplement in veggie capsules with microcrystalline cellulose excipient.
Precision Clinical Research, LLC, Sunrise
Proteimax Biotechnology Israel LTD
INDUSTRY